Results 151 to 160 of about 31,190 (230)

Momelotinib in JAK2 inhibitor-naïve myelofibrosis: pros and cons. [PDF]

Blood Cancer J
Gangat N, Tefferi A.
europepmc   +1 more source

Periportal extramedullary hematopoiesis in a patient with primary myelofibrosis: A great mimicker of an infiltrating tumor in the liver. [PDF]

Radiol Case Rep
Crawford CK, Arshad H, Kawamoto S, Fishman EK.   +3 more
europepmc   +1 more source

DNA methylation in primary myelofibrosis is partly associated with driver mutations and distinct from other myeloid malignancies. [PDF]

Clin Epigenetics
Dursun Torlak E, Tharmapalan V, Kricheldorf K, Schifflers J, Caduc M, Zenke M, Koschmieder S, Wagner W.   +7 more
europepmc   +1 more source

Extramedullary Hematopoiesis Presenting as Pleural Thickening in a Patient With Choroidal Melanoma. [PDF]

Cureus
Li S, Mubin A, Cantu D.
europepmc   +1 more source

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies [PDF]

, 2014
DiPersio, John F, et al,
core   +1 more source

Phase 1/2 study of pacritinib, a next generation JAK2/FLT3 inhibitor, in myelofibrosis or other myeloid malignancies [PDF]

, 2016

core   +1 more source

Correction: Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCT. [PDF]

Bone Marrow Transplant
Boberg E, Iacobaeus E, Greenfield MS, Wang Y, Msghina M, Le Blanc K.   +5 more
europepmc   +1 more source

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial. [PDF]

Nat Med
Rampal RK, Grosicki S, Chraniuk D, Abruzzese E, Bose P, Gerds AT, Vannucchi AM, Palandri F, Lee SE, Gupta V, Lucchesi A, Oh ST, Kuykendall AT, Patriarca A, Álvarez-Larrán A, Mesa R, Kiladjian JJ, Talpaz M, Scandura JM, Lavie D, Harris M, Kays SK, Li Q, Boxhammer R, Brown B, Jegg AM, Harrison CN, Mascarenhas J.   +27 more
europepmc   +1 more source

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I [PDF]

, 2015
DiPersio, John F, et al,
core   +2 more sources

Prevention, diagnosis and management of myeloproliferative neoplasms: an introduction to a review series. [PDF]

Haematologica
Yuan Y, Lane SW.
europepmc   +1 more source